C ancerResearchUK(2013)datashowedthatthe numberofnewpatientswithrectalcancerdiagnosed in 2010 in the UK was 13970, with approximately a quarter of these being eitherT1 orT2 N0 stage. Owing to the introduction of the National Bowel Cancer Screening Programme in 2009, the proportiondiagnosedwithearlystagediseaseisexpectedto increasefrom25%to50% (Tweedleetal,2007) .
The standard of care for rectal cancer is surgery (National Institute for Health and Clinical Excellence, 2011) .Anationalsurveyshowedthatabdomino-perineal excisionoftherectumwascarriedoutin27%ofpatients with early stage disease (Morris et al, 2008) . Surgical mortality increases with age and 30-day mortality for patients with bowel cancer above the age of 80years is 14%,increasingto25%inpatientsover90yearsofage (Tekkisetal,2005; Ruttenetal,2008) .Moreover,surgicalcomplicationsincreasewithageandmedicalcomorbidities (Ruttenetal,2008) .Therefore,itisbesttoavoid major surgery for early rectal cancer in elderly patients. Thealternativetreatmentoptionistooffercontactradiotherapy with or without external beam radiotherapy. If thereisresidualtumourattheendoftreatmentimmediatesalvagesurgerycanbeofferedwithoutcompromising thepatient'schanceofcure (HershmanandSunMyint, 2007) .
Background
Contact or Papillon radiotherapy (also know as X-ray brachytherapy) has been in clinical use for the past 80years; initially in Berlin (Chaoul and Wachsmann, 1953) then in Montpellier (Lamarque and Gros, 1946) followedbyLyon (Papillon,1974) andNice (Gérardet al, 2002) . It was introduced into the USA in the early 1970sandtheinitialencouragingresultswerevalidated in non-randomized patients (Sischy and Remmington, 1980) . Although over 2000 patients with rectal cancer have been treated using the Papillon technique, this is stillnotregardedasastandardofcareforrectalcancer.
The main drawback of this technique is the lack of large randomized trial evidence to prove its efficacy. There are several reasons for this. First, there is no replacementfortheageingPhilipsmachineswhichwere used, the production of which was stopped in the mid 1970s. Second, fewer than a dozen centres around the worldofferthisfacilityandeachhastreatedonlyasmall number of patients. Third, advances in endoscopic equipment allowing endoscopic resection and surgical technologies such as transanal endoscopic microsurgery which compete in offering treatment for patients with earlyrectalcancer.
Management of early malignant rectal polyp

Contact radiotherapy alone (T1N0M0 <3 cm)
ThistreatmentoptionshouldbeconsideredforT1rectal tumours <3cm in size without any suspicious lymph nodemetastasesordistantspread (Hershmanetal,2003; SunMyintetal,2007 (Hershman et al, 2003) . External beam radiation or preferably chemoradiation is given using either oral capecitabine 825mg/m 2 or5-flurouracilinfusion1g/m 2 concurrently with radiotherapy 45Gy in 25 fractions over 5weeks. Thedoseofchemotherapy(625mg/m 2 )andradiotherapy can be modified as necessary depending on the patient'sageandperformancestatus.Shortcourseradiotherapyalonecanbeconsideredforelderlypatientswith poor renal function (glomerular filtration rate <50ml/ min).Thetumourusuallyregressestosuperficialulcerationorasmallresidualnodule.
Good responders vs poor responders
For those who respond well after two fractions (no residualvisibleorpalpabletumour),treatmentiscontinued with contact radiotherapy for a total of four treatments(totaltumourdose110Gybutbiologicallyequiva-lentdoseishigher) (Figure 1 ).Ifthereisevidenceofsmall residualtumour(<2cm)aftercontactradiotherapy(partial responders), local excision such as transanal endoscopic microsurgery can be considered. However, if the response to contact radiotherapy is poor, with tumour regression of less than 25%, it is important to proceed with radical surgery after 8-10weeks, as these cases are unlikelytorespondtoadditionalradiotherapy (Hershman etal,2003) .
Local excision for early rectal tumours (T1N0M0 <3 cm)
ElderlypatientswithaT1N0rectaltumour<3cmwho arefitforsurgerycanbetreatedinitiallybyfullthickness excision,especiallyinsuspiciouspolypswithnoproofof malignancy even after several attempts of biopsy. If the histologyconfirmsmalignancy,withnohighriskfeatures (Table 3) , and if the resection margins are clear (R0), a watchandwaitpolicycanbeadopted(NationalInstitute for Health and Clinical Excellence, 2004, 2011) . If the resectionmarginsareinvolved(<1mm),ifthetumouris stagedaspT2orforthosewithhighriskfeatures,thereis a higher risk of local recurrence and distant metastases. Immediate completion surgery should be offered if the 
Multimodality treatment for more advanced rectal tumours (T1/T2/T3a N0 M0 >3 cm)
In elderly or high surgical risk patients with a more advancedrectaltumourlargerthan3cminsize,theinitial treatment should start with chemoradiotherapy (45Gyin25fractionsover5weekswithcapecitabine)or shortcourseexternalbeamradiotherapyalone(25Gyin five fractions over 5days) depending on the patient's general fitness and medical comorbidities. This is to downsizethetumourandinmostinstancesitalsodownstagesthetumour(T1/T2andsomeT3acanbedown-stagedtoypT0orypT1).
Theresponseisassessedbyendoscopy2-3weeksafter completionofexternalbeamradiotherapy(8weeksfrom thestartoftreatment).Iftheresidualtumourislessthan 2cm, contact radiotherapy boost can be offered to improve local control. Three fractions of 30Gy are offered over 4weeks. Further assessment, with repeat magneticresonanceimagingandcomputedtomography ofthechest,abdomenandpelvisandendoscopy,iscarriedoutat12weeks.Ifthereisnoresidualtumour(completeclinicalresponse)thenwatchandwaitpolicycanbe adopted (Hershmanetal,2003; SunMyintetal,2007) . Thepatientshouldbemadefullyawarethatthisisa non-standardtreatmentandthatsalvagesurgerywillbe necessaryintheeventofrecurrence.Thisusuallyoccurs within6-12monthsinthemajorityofcaseswithT1/T2 orT3 rectal tumours. Recurrence can still occur up to 36months but is rare after 60months (Hershman and Sun Myint, 2007) . If there is suspicion of residual tumourwithasmallnon-healingulcerormucosalabnormality, local full thickness excision using preferably transanal endoscopic microsurgery or transanal excision ofParkscanbeusedtoestablishthehistology.Inaproportion of patients there will be no residual cancer (ypT0)asthechanceofcompletepathologicalresponseis muchhigherthancompleteclinicalresponse (Gerardet al,2004) .Ifresectionmarginsareclear,thenwatchand waitpolicycanbeoffered.However,ifresectionmargins areinvolved(<1mm),thencompletionsurgeryshouldbe offeredtothosewhoarefitandagreetosalvagesurgery.
Theinterpretationofhistologyafterchemoradiotherapyandcontactradiotherapycanbedifficultevenforan experiencedpathologist.Therefore,biopsyofthetreated areaisnotadvisableifthereisnoresidualabnormalityas thiscancausepersistentresidualulcerationorpain.Ifin doubt,fullthicknessexcisionwithtransanalendoscopic microsurgeryshouldbecarriedouttoclarifytheresidualtumourstatus.Therestagingmagneticresonanceimaging scans following chemoradiation can be difficult to interpret, even by an experienced radiologist, and it is important to repeat magnetic resonance imaging scan every 3months. In the authors' experience, if there is a residual tumour it will grow within 6-12months (Hershmanetal,2003; HershmanandSunMyint,2007; Sun Myint et al, 2007) . magnetic resonance imaging abnormalitiesshouldbeinterpretedinconjunctionwith endoscopy. Digital examination can be useful to assess whether there is residual tumour in patients with low rectal cancer. The patient should be fully aware of the uncertaintiesandlimitationsofcurrentlyavailableinvestigationsandacceptthatsalvagesurgerymaybenecessary toresolvetheissue.Difficultcasesshouldbediscussedat the local colorectal multidisciplinary team meeting and referredtoaspecialistcentrewithanexperiencedmultidisciplinaryteamforanopinion.
Complete response in more advanced rectal cancers (T3/N1/M0)
There is an increasing awareness of complete response following preoperative chemoradiotherapy for advanced rectal cancers.This was first observed by the San Paulo group who reported the concept of 'wait and watch' or delayedsurgery (Habr-Gamaetal,2004) .Thechanceof local control and cure was not compromised in the cohorts observed and local recurrence could be treated withoutaffectingthelong-termsurvival(Habr-Gamaet al,2006). A number of international centres are involved in clinical trials to evaluate this further. In the UK, the MERCURY group is conducting a trial on deferral of surgery in complete responders. The North West Colorectalgroup,whichincludesClatterbridge,Preston, NorthWalesandChristie,isauditingcompleteresponders.Thereareotherreportspublishedonfavourablesingleinstitutionandmulticentredpooleddataexperiences (Maasetal,2010 (Maasetal, ,2011 .TheSanPaulogroupcontinues topublishitsencouragingmaturedatawhicharebeing observed carefully by surgical communities around the world (Habr-Gamaetal,2010) .
Whatever the long-term outcome is, many elderly patientsaresparedradicalsurgerywithoutcompromising theirchanceofcure.Thereisconcernaboutsubmucosal residualnestsofcancercellswhichcannotbedetectedon endoscopyorseenonmagneticresonanceimagingscans. Smallvolumesofresidualcancercellscanbedetectedin theoperativespecimensinpatientswhohadsurgeryand arenotkeentobewatched (Smithetal,2012) .Thismay beanareawhereacontactradiotherapyboostplaysarole as a very high biological dose of radiation is applied directly to the residual tumour with minimal effect on normalsurroundingtissues.Thehighdoseofradiationis limitedtoonlyafewmillimetresofbowelwall (Gerardet al, 2011) . The OPERA and CONTEM-5 trials which evaluatetheroleofthecontactradiotherapyboostmay shedsomelightonthisissue.
Suspicious lymph nodes
Themajorityofearlystagedrectaltumoursdonothave lymphnodespread(<10%).Smalllymphnodes(<5mm) aredifficulttoevaluateaccuratelyusingcurrentinvestigational tools including magnetic resonance imaging. If thereissuspicionoflymphnodeinvolvementonendorectalultrasoundormagneticresonanceimaging,thepolicy oftheauthor'sunitistoofferexternalbeamchemoradiotherapy or radiotherapy to sterilize these lymph nodes. Thereisnowagrowingamountofpublisheddataonthe effectivenessofradiationinsterilizinglymphnodesfollowing preoperative chemoradiation.The probability of residual disease in the lymph node for T3 primary tumourswhichhavebeendownstagedtoypT0/ypT1was 2% (Readetal,2004 ).However,foradvancedunresectable T3-T4 rectal tumour 17% of lymph nodes were found to be involved despite complete response in the primarytumourtoypT0 (Hughesetal,2006) .Therefore, caution is needed before advocating a watch and wait policy in a patient with a very advanced unresectable primarytumourthatwasdownstagedafterchemoradiotherapy. A restaging scan 6-8weeks after treatment is important. If this shows regression of lymph nodes one can continuetoadoptawatchandwaitpolicy.Iftherestaging scan shows progression (rare in the author's experience),thenimmediatesalvagesurgeryisrecommendedin thosepatientswhoarefit.Theroleofthepositronemission tomography/computed tomography scan is still underevaluationandmayhelpinsomecasesbutnotin the majority of cases as the equivocal lymph nodes are usually<10mm (Goldbergetal,2012) .
Distant metastases
Thechanceofdistantmetastasesislessthan5%forearly tumoursintheauthors'experience (HershmanandSun Myint,2007) .Ifdistantmetastasesdevelopduringfollow up,surgicalresectionisoffered(iftheseareoperable)for either liver or lung metastases. Contact radiotherapy boosttoimprovelocalcontrolcansometimesbeoffered as a palliative treatment to avoid major surgery in patientspresentingwithinoperablemetastaticdisease.
Follow up
Closefollowupisnecessarytodetectearlyrecurrenceso thatsalvagesurgerycanbecarriedout.Ninetypercentof recurrencesoccurwiththefirst2-3years (Hershmanand SunMyint,2007) .
There are no national or international guidelines on thefollowupofpatientswithcompleteclinicalresponse. Theintensityoffollowupneedstobebalancedcarefully withinconveniencetopatientsandthecostofinvestigationsinvolved.Theauthorsrecommendthatduringthe periodofhighrisk(usuallyinthefirst2years)endoscopy shouldbecarriedoutevery3monthstodetectendolumi-nal recurrences together with an magnetic resonance imaging scan undertaken to detect extraluminal and nodalrecurrences.CTscansofthechest,abdomenand pelvisshouldbecarriedoutat6,12,24and36months. Colonoscopyshouldbecarriedoutaspernationalguidelines.
Side effects
There is no reported mortality associated with contact radiotherapy. The main side effect is bleeding which occursin26%ofcasesasaresultoftelangiectasiaaround thePapillonscar (Figure 2) .Bleedingusuallysettlesafter 3-12months.
Patients who are taking anticoagulants or antiplatelet agentscanhavepersistentbleedingandtheauthorshave foundthatplasmaargoncoagulationcanbeusefulifthe 
Is contact radiotherapy cost effective?
Followingextirpativesurgeryathirdofpatientsendup withapermanentcolostomy,includingsomewithtemporarystomasthatbecamepermanent(NationalInstitute for Health and Clinical Excellence, 2011) .The cost of stoma bags varies depending on many factors, but on average,stomabagscosttheNHS£6-8Kperpatientper annum. At present, a third of patients with early stage rectalcancerintheUKareofferedpermanentstomasas they are situated in the lower third of rectum (<6cm) (Morris et al, 2008) . If these patients can be offered organ-sparing treatments such as contact radiotherapy withorwithoutlocalexcision,over2000patientswillbe sparedastoma.Thisofferssubstantialcostsavings(inthe region of £50-100million) for the NHS. Health-care policymakersshouldlookintothiscarefully.
Discussion
The standard of surgical care for low rectal cancer is abdomino-perineal excision with a permanent stoma (National Institute for Health and Clinical Excellence, 2004,2011) .However,mortalityandmorbidityarehigh, especiallyinelderlypatients (Tekkisetal,2005; Rutten etal,2008) .Thisisbecominganimportantissueasthe ageingpopulationintheUKandotherwesterncountries is increasing. The number of people above the age of 85years will increase from 1.3million to 3.3million by 2033 in the UK. In addition, the quality of life for patientswhohaveextirpativesurgeryandthecreationof astomaispoor (Tekkisetal,2005; Ruttenetal,2008 
Contact radiotherapy in the UK
A team from Clatterbridge visited Lyon to study this technique in 1992 and the first contact radiotherapy facilitywassetupatClatterbridgein1993.Since2005 regular international annual meetings have been held at Clatterbridge. Ariane (a British company based in Nottingham) became interested in developing and producinganewcontactradiotherapymachineandthefirst prototype machine of its kind was made available for clinicaluseatClatterbridge.Thefirstpatientwastreated usingthenewmachineinOctober2009 (SunMyintet al,2011 ). In total nearly 700 patients have been treated over 20years at Clatterbridge. Training courses for contact radiotherapy were set up at Clatterbridge to train clinicians from other centres. Over 10 centres from around the world have received training and four centres now offercontactradiotherapyusingthisnewmachine.The secondfacilityintheUKwassetupatHullinSeptember 2011 and over 25 patients have since been treated successfully.ThereareplansformorecentresintheUKto setupthisfacilitywhichwillprovidetreatmentlocallyfor elderlypatientsnearerhome.
Plansarealsoinplacetosetupaninternationaldatabaseforanaudittoevaluatetheresultsofpatientstreated under strict CONTEM protocols which are observational studies (Lindegaard et al, 2007) . Several randomizedtrialssuchasOPERAandCONTEM-5arealso planned. Until results of these trials are available, the controversyaroundofferingcontactradiotherapytoelderlypatientswithearlyrectalcancerwillcontinue.Inthe mean time, it is important for colorectal multidisciplinaryteamstorecognizethepotentialforthistreatment option so that elderly patients, high anaesthetic risk patientsandthosewhoarenotkeenonhavingapermanentstomadonotmissthechanceofbetterlocalcontrol andimprovequalityoflife.
Conclusions
Manyelderlypatientswithearlyrectalcancerwouldlike toavoidmajorsurgeryifpossible.Contactradiotherapy shouldbeconsideredforhighanaestheticriskandelderly patients with low early stage rectal cancer. National guidelinesareurgentlyneededsothatcolorectalmultidisciplinaryteamscanconsidercontactradiotherapyasone ofthetreatmentoptionsforsuitablepatientswithearly rectalcancer.
